ARIA: I guess nothing was learned. Perfect example of how a dysfunctional biotech company taking excessive risk and potentially wasting money in the process. Run a large dose ranging trial at the same time as a large randomized trial in earlier line? If you don't know what's the best dosing regimen is, how could you run a large randomized trial for early line at the same time?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.